Protara Therapeutics, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Protara Therapeutics, Inc. (TARA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $27.80 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-03-09
- Protara Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $27.80M, a 28.11% increase from fiscal 2020.
- Protara Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $21.70M, a 416.67% increase from fiscal 2019.
- Protara Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $4.20M.
- Protara Therapeutics, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was -$54.10M, a 714.77% decline from fiscal 2016.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2021-12-31 | $27.80M 10-K · filed 2022-03-09 |
| 2020-12-31 | $21.70M 10-K · filed 2022-03-09 |
| 2019-12-31 | $4.20M 10-K · filed 2021-03-11 |
| 2017-12-31 | -$54.10M 10-K · filed 2019-03-13 |
| 2016-12-31 | $8.80M 10-K · filed 2019-03-13 |
| 2015-12-31 | $9.80M 10-K · filed 2018-03-14 |
| 2014-12-31 | $3.80M 10-K · filed 2017-03-16 |
| 2013-12-31 | $7.30M 10-K · filed 2016-03-14 |
| 2012-12-31 | $3.00M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |